
President, Cardinal Consulting and Training
Member of the Healthcare Council
Jim Farley is an Independent Consultant and Owner of Cardinal Consulting and Training. Formerly, Mr. Farley served as the Director of the Science Branch of Philadelphia District FDA. He has over 30 years of experience in pharmaceutical and pharmaceutical packaging industries with extensive experience in the areas of laboratory management and Food and Drug Administration regulations. Mr. Farley has held various technical management positions in quality control, technical service, and as the Director of Research and Development in pharmaceutical packaging. (This is me - Update Profile)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Watson Pharmaceutical's Acquisition of Andrx
May 17, 2006
Watson to Acquire Drug Rival Andrx | pubs.acs.org
If the deal goes through, the estimated year 2007 revenues, according to Watson, would be $2.8 billion.
India is strong in Pharmaceutical Area
May 11, 2006
Science in India | www.cen-online.org
More sources of Pharmaceutical Materials such as Active Pharmaceutical Ingredients (API). Possible better prices.
| Study Group Name | No. Members |
|---|---|
| Experts in the Leisure & Lodging Council | 4887 |
| Experts in the Automotive Council | 3422 |
| Generic Drug Economic Experts | 766 |
| Medical Device Experts | 317 |
| Medical Geneticists (US) | 85 |
Jim Farley has not participated in any GLG Live Meetings.